Lakeshore Biopharma CO., LTD. (LSBWF) — 20-F Filings
All 20-F filings from Lakeshore Biopharma CO., LTD.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
LakeShore Biopharma's Losses Widen Amid Revenue Dip, R&D Surge
— Jul 31, 2025 Risk: high
LakeShore Biopharma Co., Ltd. (LSBWF) reported a net loss of $35.2 million for the fiscal year ended March 31, 2025, a significant increase from the $28.5 milli -
LakeShore Biopharma Files 2024 Annual Report
— Aug 15, 2024 Risk: medium
LakeShore Biopharma Co., Ltd. filed its annual report on Form 20-F for the fiscal year ended March 31, 2024. The company, formerly known as YS Biopharma Co., Lt
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX